Published in Blood Weekly, November 16th, 2006
According to recent research from the People's Republic of China, "In order to explore the methods for commercialized bone tissue engineering, engineered bones should be cultivated in bioreactors to realize 3-dimensional culture under well-defined culture conditions.
"In the present paper, osteoblasts isolated from the cranium of 1-month-old Zelanian rabbits were inoculated on to the BDBS (bioderived bone scaffolds) to investigate the 3-dimensional fabrication of engineered bone in an RWVB (rotating-wall vessel bioreactor)."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.